The efficacy and safety of vidldagliptin combined with acarbose in treating type 2 diabetes / 实用医学杂志
The Journal of Practical Medicine
;
(24): 3312-3314, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-503223
ABSTRACT
Objective To observe the efficacy and safety of vildagliptin combined with acarbose in treating type 2 diabetes. Methods 78 patients with type 2 diabetes were divided into two groups to have additional vildagliptin combined with acarbose or acarbose combined with placebo. The clinical efficacy and adverse reactions after 12 weeks were investigated. Results In the treatment group, FBG, 2 h PG and HbA1C declined after treatment (P 0.05). There were either liver and kidney damage (P > 0.05), nor hypoglycemia. Conclusion Vildagliptin combined with acarbose is superior to Acarbose combined with placebo , and it produced no more untoward effect.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
The Journal of Practical Medicine
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS